Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CLXT

Calyxt (CLXT) Stock Price, News & Analysis

Calyxt logo

About Calyxt Stock (NASDAQ:CLXT)

Advanced Chart

Key Stats

Today's Range
$6.01
$7.77
50-Day Range
$6.30
$31.50
52-Week Range
$1.25
$7.77
Volume
254,056 shs
Average Volume
139,308 shs
Market Capitalization
$31.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLXT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calyxt and its competitors with MarketBeat's FREE daily newsletter.

CLXT Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
Calyxt Completes One-for-Ten Reverse Stock Split
Calyxt Announces Effective Date of Reverse Stock Split
See More Headlines

CLXT Stock Analysis - Frequently Asked Questions

Calyxt, Inc. (NASDAQ:CLXT) released its earnings results on Monday, May, 1st. The company reported ($5.45) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.00) by $2.45. The firm earned $0.04 million during the quarter. Calyxt had a negative net margin of 9,979.64% and a negative trailing twelve-month return on equity of 259.69%.

Calyxt's stock reverse split on Thursday, June 1st 2023.The 1-5 reverse split was announced on Thursday, June 1st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Calyxt (CLXT) raised $101 million in an initial public offering (IPO) on Thursday, July 20th 2017. The company issued 6,100,000 shares at $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities served as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Calyxt investors own include Cellectis (CLLS), Intel (INTC), Plug Power (PLUG), First Solar (FSLR), Intellia Therapeutics (NTLA), NVIDIA (NVDA) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
5/01/2023
Today
8/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:CLXT
CIK
1705843
Fax
N/A
Employees
48
Year Founded
2001

Profitability

EPS (Trailing Twelve Months)
($3.49)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.89 million
Net Margins
-9,979.64%
Pretax Margin
-9,979.64%
Return on Equity
-259.69%
Return on Assets
-83.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.61
Quick Ratio
0.61

Sales & Book Value

Annual Sales
$160 thousand
Price / Sales
195.69
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.54 per share
Price / Book
11.67

Miscellaneous

Outstanding Shares
4,970,000
Free Float
4,865,000
Market Cap
$31.31 million
Optionable
Not Optionable
Beta
1.98

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:CLXT) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners